Douglas Crawford’s goal is to help entrepreneurial scientists create successful startups. Doug created MBC BioLabs in San Francisco which has helped launch 131 companies that have raised over $3.5B. Doug is also the Managing Director of Mission Bay Capital. Doug received his PhD in biochemistry from UCSF.
Worked for over 15 years in the pharmaceutical industry. Responsible of Amgen’s third product. Helped innovative SMEs develop for over 10 years, in Europe and in the US. Biotechnology, Business Development, Cleantech. Currently working with BioLabs (biolabs.io), which is expanding internationally.
Leads new program business development and search and evaluation at PureTech. Previously led R&D and business development for Sonde Health, a PureTech affiliate company. Ph.D scientist by training. Background in venture creation and program strategy in therapeutics and devices.
After engaging in basic research (molecular biology and immunology) at the University of Toronto, RIKEN and etc., I have been involved in various open innovation activities in especially the Drug Discovery Stage at global pharmaceutical companies such as Boehringer Ingelheim. I got current position this year. Ph.D. in Pharmaceutical Sciences (Osaka University).
Taku is a startup accelerator and a venture capitalist focusing on future businesses with life science and computer science. Taku is a venture partner at Fast Track Initiative, Inc. since Jan 2019. Formerly, Taku served as an assistant professor at two universities and joined an US startup as a founding member who led R&D in bioinformatics, and led new business development in a Japanese business company.
After working for pharma company as a researcher for 7 years, working for another pharma companies for 20 years as in-house patent attorney to prepare IP strategies. In 2017, established Uchiyama IP Strategies to provide IP strategies to Pharma/bio venture companies, small companies and academias.
Support the health-tech business development. Share industrial knowledge and global trends around cloud technologies in BioPharma, Payer, and Provider market segments; help build data analysis platform, wearables and PHR apps. Have CxO experience in startups in Australia and Japan.